NO20050337L - Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat - Google Patents
Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparatInfo
- Publication number
- NO20050337L NO20050337L NO20050337A NO20050337A NO20050337L NO 20050337 L NO20050337 L NO 20050337L NO 20050337 A NO20050337 A NO 20050337A NO 20050337 A NO20050337 A NO 20050337A NO 20050337 L NO20050337 L NO 20050337L
- Authority
- NO
- Norway
- Prior art keywords
- dosage form
- liquid
- liquid formulation
- formulation
- controlled release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Abstract
Det beskrives en doseringsform for kontrollert frigivning for avlevering av en flytende aktiv bestanddelsformulering. Doseringsformen omfatter et reservoar tildannet av et vannimpermeabelt materiale og er fylt med en flytende aktiv bestanddelsformulering. Doseringsformen inkluderer også et ekspanderbart, osmotisk preparat anordnet i reservoaret og eventuelt er dette separert fra kontakt med den flytende formulering ved hjelp av et barrieresjikt som i det vesentlige er impermeabelt for passasje av væske. For å lette utstøting av flytende formulering, inkluderer doseringsformen også en utløpsåpning. Materialvalg og konstruksjon for reservoaret i doseringsformen tillater fremstilling av orale doseringsformer som er i stand til mer konsistent å gi en ønsket frigivningshastighet eller frigivningshastighetsprofil for aktivbestanddelen fra en flytende formulering.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39277402P | 2002-06-28 | 2002-06-28 | |
PCT/US2003/020422 WO2004002448A1 (en) | 2002-06-28 | 2003-06-27 | Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050337L true NO20050337L (no) | 2005-01-21 |
Family
ID=30000933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050337A NO20050337L (no) | 2002-06-28 | 2005-01-21 | Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040058000A1 (no) |
EP (1) | EP1521570A1 (no) |
JP (1) | JP2005533084A (no) |
KR (1) | KR20050071376A (no) |
CN (1) | CN1678291A (no) |
AR (1) | AR040306A1 (no) |
AU (1) | AU2003245738A1 (no) |
CA (1) | CA2490412A1 (no) |
IL (1) | IL166023A0 (no) |
MX (1) | MXPA05000206A (no) |
NO (1) | NO20050337L (no) |
NZ (1) | NZ537492A (no) |
TW (1) | TW200531708A (no) |
WO (1) | WO2004002448A1 (no) |
ZA (1) | ZA200500834B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1648409A2 (en) * | 2003-07-31 | 2006-04-26 | Alza Corporation | Permeation-resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation |
AU2004314693B2 (en) | 2003-09-26 | 2011-04-07 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
KR20060070575A (ko) * | 2003-09-26 | 2006-06-23 | 알자 코포레이션 | 활성성분 제제의 방출제어용 제형 |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20070014847A1 (en) * | 2005-07-05 | 2007-01-18 | Ahmed Salah U | Coated capsules and methods of making and using the same |
FR2934805A1 (fr) | 2008-08-07 | 2010-02-12 | Inergy Automotive Systems Res | Procede pour fixer un accessoire dans un corps creux en matiere plastique lors de son moulage. |
JP2023516370A (ja) * | 2020-03-02 | 2023-04-19 | クラフト ヘルス プライベート リミテッド | 持続的薬物放出のための経口剤形 |
CN115490316B (zh) * | 2022-01-24 | 2023-09-12 | 成都理工大学 | 一种可再利用的地下水营养物质缓释胶囊体 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US36472A (en) * | 1862-09-16 | Cttlvebt | ||
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
US5223265A (en) * | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery |
EP0804174A4 (en) * | 1993-07-21 | 1998-09-09 | Univ Kentucky Res Found | MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS |
GB9326267D0 (en) * | 1993-12-23 | 1994-02-23 | Scherer Corp R P | Expulsion of material |
US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
DK1066081T3 (da) * | 1996-11-15 | 2003-12-01 | Alza Corp | Osmotisk leveringssystem og fremgangsmåde til at forbedre osmotiske leveringssystemers igangsættelse og gennemførelse |
US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
US6551613B1 (en) * | 1998-09-08 | 2003-04-22 | Alza Corporation | Dosage form comprising therapeutic formulation |
US6174547B1 (en) * | 1999-07-14 | 2001-01-16 | Alza Corporation | Dosage form comprising liquid formulation |
WO2000035419A2 (en) * | 1998-12-17 | 2000-06-22 | Alza Corporation | Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
ATE306250T1 (de) * | 1998-12-23 | 2005-10-15 | Alza Corp | Dosierungsformen, die poröse partikel enthalten |
AU2084801A (en) * | 1999-12-09 | 2001-06-18 | Alza Corporation | Antiviral medication |
WO2003053400A1 (en) * | 2001-12-19 | 2003-07-03 | Alza Corporation | Formulation & dosage form for the controlled delivery of therapeutic agents |
CA2471096A1 (en) * | 2001-12-19 | 2003-07-03 | Alza Corporation | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
-
2003
- 2003-06-27 MX MXPA05000206A patent/MXPA05000206A/es not_active Application Discontinuation
- 2003-06-27 EP EP03739346A patent/EP1521570A1/en not_active Withdrawn
- 2003-06-27 NZ NZ537492A patent/NZ537492A/en not_active IP Right Cessation
- 2003-06-27 AR ARP030102346A patent/AR040306A1/es not_active Application Discontinuation
- 2003-06-27 AU AU2003245738A patent/AU2003245738A1/en not_active Abandoned
- 2003-06-27 JP JP2004518034A patent/JP2005533084A/ja not_active Withdrawn
- 2003-06-27 IL IL16602303A patent/IL166023A0/xx unknown
- 2003-06-27 US US10/608,305 patent/US20040058000A1/en not_active Abandoned
- 2003-06-27 KR KR1020047021486A patent/KR20050071376A/ko not_active Application Discontinuation
- 2003-06-27 CA CA002490412A patent/CA2490412A1/en not_active Abandoned
- 2003-06-27 WO PCT/US2003/020422 patent/WO2004002448A1/en active Application Filing
- 2003-06-27 CN CNA038205696A patent/CN1678291A/zh active Pending
-
2004
- 2004-03-19 TW TW093107362A patent/TW200531708A/zh unknown
-
2005
- 2005-01-21 NO NO20050337A patent/NO20050337L/no not_active Application Discontinuation
- 2005-01-27 ZA ZA200500834A patent/ZA200500834B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2490412A1 (en) | 2004-01-08 |
ZA200500834B (en) | 2006-04-26 |
WO2004002448A1 (en) | 2004-01-08 |
NZ537492A (en) | 2007-10-26 |
TW200531708A (en) | 2005-10-01 |
US20040058000A1 (en) | 2004-03-25 |
MXPA05000206A (es) | 2005-12-05 |
AU2003245738A1 (en) | 2004-01-19 |
IL166023A0 (en) | 2006-01-15 |
EP1521570A1 (en) | 2005-04-13 |
KR20050071376A (ko) | 2005-07-07 |
AR040306A1 (es) | 2005-03-23 |
CN1678291A (zh) | 2005-10-05 |
JP2005533084A (ja) | 2005-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050337L (no) | Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat | |
BRPI0414941A (pt) | dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente | |
WO2005065319A3 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
WO2006123357A3 (en) | Oral controlled release composition containing levetiracetam | |
WO2006011159A3 (en) | Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability | |
ATE504288T1 (de) | Oros-push-stick für die kontrollierte abgabe von wirkstoffen | |
HRP20040323C1 (hr) | Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli s produljenim oslobađanjem djelotvone supstance | |
NO20092998L (no) | Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden | |
WO2007016388A3 (en) | Liquid formulations for controlled delivery of benzisoxazole derivatives | |
ITMI951223A1 (it) | Forma farmaceutica solida ad uso orale | |
FR2889811B1 (fr) | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. | |
NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
BR0011641A (pt) | Aparelho de distribuição de isca-e-troca para insetos | |
NO20072257L (no) | Nye tablettformuleringer med modifisert frigivning for protonpumpeinhibitorer | |
CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
WO2005016306A3 (en) | Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation | |
WO2005079750A3 (en) | Films for use as dosage forms | |
MX2010007281A (es) | Composiciones farmaceuticas de amlodipina y valsartan. | |
WO2006108692A3 (en) | Dosage form for oral administration of a vitamin | |
WO2005063203A3 (en) | Multiparticulate formulations for oral delivery | |
JP2006525315A5 (no) | ||
CN109152773A (zh) | 用于治疗无烟烟草成瘾的含有大麻二酚和尼古丁的药物制剂 | |
CA2937654A1 (en) | Dental treatment capsule, formulation and device | |
WO2004034962A3 (en) | Selective cytokine inhibitory drugs for treating myelodysplastic syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |